［1］ Wahl D，Bernier M，Simpson SJ，et al.Future directions of resveratrol research［J］.Nutr Healthy Aging，2018,4(4):287-290.
［2］ Pallauf K，Rimbach G，Ropp PM，et al.Resveratrol and lifespan in model organisms［J］.Curr Med Chem，2016,23(4):4639-4680.
［3］AN Mei，ZHOU Jin，CHEN Xiaoyu.Pharmacological activities of resveratrol and protection research progress on the body［J］.Anti-tumor Pharmacy，2014,4(4):242-246.［安梅，周瑾，陈晓宇.白藜芦醇药理学作用的研究进展［J］.肿瘤药学，2014，4(4):242-246.］
［4］ D Wen，X Huang，M Zhang，et al.Resveratrol attenuates diabetic nephropathy via modulating angiogenesis［J］.PLoS One，2013,8(12):e82336.
［5］ WY Oh，F Shahidi.Antioxidant acticity of resveratrol ester dervertives in food and biological model systems［J］.Food Chemistry，2018,261(2018):267-273.
［6］ Lei Yang，Zhen Zhang，Yuzhen Zhuo，et al.Resveratrol alleviates sepsis-induced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells［J］.Am J Transl Res,2018,10(7):1961-1975.
［7］ A Ratzlyko，J Arct.Resveratrol as an active ingredient for cosmetic and dermatological applications:A review［J］.J Cosmet Laser Ther,2018(8):1-7.
［8］ AK Singh，S Kumar，M Vinayak.Recent development in antihyperalgesic effect of phytochemicals:anti-inflammatory and neuro-modulatory actions［J］.Inflammation Research,2018,66(9):1-22.
［9］ SR Beedanagari，I Bebenek，P Bui，et al.Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase Ⅱ to the regulatory regions of the corresponding genes［J］.Toxicoloblcal Sciences，2009,110(1):61-67.
［10］ B Loai，S Keren，K Zohar.Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in vitro and in silico models［J］.Sceientific Reports，2016(6):31557.
［11］ Ware WR.Natural cancer therapy and prevention targeted on cancer cells and cancer stem cells based on the cytochrome P450 enzyme CYP1B1：A commentary［J］.Alterm Ther Health Med，2017,23(5):50-58.
［12］ D'Uva G，Baci D，Albini A，et al.Cancer chemoprevention revisited：Cytochrome P450 family 1B1 as a target in the tumor and the microenviroment［J］.Cancer Treat Rev，2018(63):1-18.
［13］ W Nawaz，Z Zhou，S Deng，et al.Therapeutic versatility of resveratrol derevatives［J］.Nutrients，2017,9(11):1188-1213.
［14］ Pan MH，Lin CL，Tsai JH，et al.3,5,3',4',5'-Pentanmethoxystilbene(MR-5)，a synthetically methoxylated analogue of reveratrol derivative，inhibitis growth and induces G1 cell cycle of human breast carcinoma MCF-7 cells［J］.J Agric Food Chem，2010,58(1):226-234.
［15］ H Li，WK Wu，Z Zheng，et al.2,3',4,4',5'-Pentanmethoxy-trans-stilbene，a resveratrol derivative，is a potent induce of apoptosis in colon cancer cells via targeting microtubules［J］.Biochemical Pharmaclogy，2009，78(9):1224-1232.
［16］ Zykova TA，Zhu F，Zhai X，et al.Resveratrol directly targets COX-2 to inhibit carcinogenesis［J］.Mol Carcinog，2008,47(10):797-805.
［17］ Kundu JK，Shin YK，Surh YJ.Resveratrol modulates phorbol ester-induced pro-inflammatory［J］.Biochem Pharmacol,2006,72(11):1506-1515.
［18］ M Elshaer，Y Chen，XJ Wang，et al.Resveratrol：An overview of its anti-cancer mechanisms［J］.Life Sciences，2018,207(2018):340-349.
［19］ Cheng TM，Chin YT，Ho Y，et al.Resveratrol induce sumoylated COX-2-dependent anti-proliferation in human prostate cancer LNCaP cells［J］.Food Chem Toxicol，2018(112):67-75.
［20］ AC Faber，FJ Dufort，D Blaie，et al.Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas［J］.Biochem Pharmacol，2006,72(10):1246-1256.
［21］ G Mosieniak，MA Sliwinska，D Przyblska，et al.Curcumin-treated caner cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype［J］.Int J Biochem Cell Biol，2016(74):33-43.
［22］ SK Singh，S Banerjee，EP Acosta，et al.Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway［J］.Oncotarget，2017,8(10):17216-17228.
［23］ Yang Q，Wang B，Zang W，et al.Resveratrol inhibits the growth of gastric cancer by inducing phase arrest and senescence in a Sirt1-dependent manner［J］.PLoS One，2013,8(11):e70627.
［24］ Zhang Q，Bergman J，Wiman J，et al.Role of thiol reactivity for targeting mutant p53［J］.Torque,Drag & Hydraulics Software,2018,S2451-9456(1):30227.
［25］ Bellazzo A，Sicari D,Valentino E，et al.Complexes formed by mutant p53 and their roles in breast cancer［J］.Breast Cancer,2018(10):101-112.
［26］ DC Ferraz，C Npc，RA Santos，et al.Resveratrol prevents p53 aggregation in vitro and in breast cancer cells［J］.Oncotarget，2018,9(49):29112-29122.
［27］ Kong Y，Chen J，Zhou Z，et al.Cucurbitacin E induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancer［J］.PLoS One，2014,9(7):e103760.
［28］ R Venkatadri，T Muni，AK Iyer，et al.Role of apoptosis-related miRNA in resveratrol-induced breast cancer cell death［J］.Cell Death and Disase，2016,7(2):e2014.
［29］ Z Jehan，AR Hussain，M Ahmed，et al.Resveratrol suppresses constitutive activation of Akt via generation of reactive oxygen species and induces apoptosis in diffuse large B cell lymphoma cell lines［J］.Cancer Research，2011,71(8):4778.
［30］ Rasheduzzaman M，Jeong JK，Park SY.et al.Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling［J］.Life Sci，2018,208(18):208-220.
［31］ AR Pavan，GD Silva，DH Jornada，et al.Unraveling the anticancer effect of curcumin and resveratrol［J］.Nutrients，2016,8(11):628-677.
［32］ AB Tino，K Chitcholtan，PH Sykes，et al.Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein［J］.Journal of Ovarian Research，2016,9(1):84-99.
［33］ M Zhang，W Li，L Yu，et al.The suppressive effect of resveratrol on HIF-α and VEGF expression after warm ischemia and reperfusion in rat liver［J］.PLoS One，2014,8(10):e109589.
［34］EM Varoni，LFA Fabrizio，SR Javad，et al.Anticancer molecular mechanism of resveratrol［J］.Frontiers in Nutrition，2016,3(Suppl):82-83.
［35］W Li，J Ma，Q Ma，et al.Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway［J］.Current Medicine Chemistry，2013,20(33):4185-4194.
［36］ Q Xu，L Zong，X Chen，et al.Resveratrol in the treatment of pancreatic cancer［J］.Ann N Y Acad Sci，2015,1348(1):10-19.
［37］ C Buhrmann，P Shayan，A Goel，et al.Resveratrol regulates colorectal cancer cell invasion by modulation of focal adhesion molecules［J］.Nutrients，2017,9(10):1073-1094.
［38］ H Zhao，S Chen，K Gao，et al.Resveratrol protects aganist spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway［J］.Neuroscience,2017(348):241-251.
［39］ Steeg PS.Targeting metastasis［J］.Nat Rev Cancer，2016,16(4):201-218.
［40］ JH Ko，G Sethi，JY Um，et al.The role of resveratrol in cancer therapy［J］.Int J Mol Sci，2017,18(12):2589-2624.
［41］ Rong Chai，H Fu，Z Zheng，et al.Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells［J］.Molecular Medicine Reports，2017,16(6)：8037-8044.
［42］ Liu MH，Lin XL，Li J，et al.Resveratrol induces apoptosis through modulation of tje Akt/FoxO3a/Bim pathway in HepG2 cells［J］.Mol Med Rep，2016,13(2)：1689-1694.
［43］ K Rifai，M Idrissou，M Daures，et al.Sirt1 in colorectal cancer：A friend or foe［J］.Omiics A Journal of Integrative Biology，2018,22(4):298-300.